![](https://d3ilqtpdwi981i.cloudfront.net/ysHZ4q1ATwny4-n6peuf9ntXrPA=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/4d/4f/d0/4d4fd02a-a5b4-4036-accc-9f3c50faa482/thumbnail_c91e16bd-555c-450e-b5a5-9c3c7e0c7b0d.jpg)
Introduction
The management of patients with residual masses following chemotherapy for advanced seminoma remains a difficult problem with no clear guidelines. While most patients with advanced seminoma achieve a complete or partial response with cisplatin based chemotherapy1, a significant number will reveal a residual mass on follow up CT scan or MR imaging2,3. Management options for post chemotherapy residual mass in a case of seminoma include close observation, radiation therapy and excisional surgery. While 80 to 85% of residual masses represent either fibrosis or necrotic tissue needing no further therapy, 10 to 15% may contain viable tumor which, if not recognized and effectively treated, may be lethal. A case of a stage II seminoma with post chemotherapy residual mass is presented and contemporary literature on this topic is reviewed.
Available at: http://works.bepress.com/farhat_abbas/25/